2m 2m 2m 2m 2m 2m 2m
Aclaris Therap (ACRS)
NASDAQ
$5.44+$0.11 (+2.16%)
Price as of Sep 11, 2026 7:43 PM EDT- $783.1MMarket Cap
- 172.82%1-Year Change
- BiotechnologyIndustry
Aclaris Therap (ACRS)
$5.44+$0.11 (+2.16%)
ACRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.32 | ||
Change | -$0.18 (-3.36%) | ||
Open | $5.50 | ||
High | $5.59 | ||
Low | $5.17 | ||
Previous Close | $5.50 | ||
Volume | 3,278,158 | ||
30-Day Average Volume | 1,844,857 | ||
1-Week Change | -13.78% | ||
1-Month Change | -10.14% | ||
1-Year Change | 172.82% | ||
3-Year Change | -32.06% | ||
5-Year Change | -69.84% | ||
Fundamentals | |||
Shares Outstanding | 147.2M | ||
Total Assets | $179.7M | ||
Market Cap | $783.1M | ||
Enterprise Value | $763.9M | ||
Period: QTR TTM FY | |||
Revenue | $356,000.00 | ||
Net Income | -$21.5M | ||
Free Cash Flow | -$19.9M | ||
EBIT | -$21.5M | ||
EBITDA | -$21.4M | ||
Net Working Capital | $69.5M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | 2,146 | ||
P/B | 6 | ||
P/E | -35 | ||
PEG | N/A | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue